CLDXCelldex Therapeutics, Inc.
$29.26+10% 1Y
$29.26
$22.5852 weeks$44.88
Is the price fair?
What CLDX's price assumes
Celldex Therapeutics, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 14543× revenue.
14543
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 3.22
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 11261
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 3.22
- EV / EBIToperating margin −206220%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 11261
- Market capitalisation78.5 million shares, counted Jul 29, 2026
- $2.30B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
On our screens:Most shorted stocks